Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk
about
Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkersEffects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitusNoninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform?Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary diseaseThe relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis.Determinants of arterial stiffness in COPDRate of decline of forced vital capacity predicts future arterial hypertension: the Coronary Artery Risk Development in Young Adults Study.Physical inactivity and arterial stiffness in COPD.Central arterial stiffness is increased among subjects with severe and very severe COPD: report from a population-based cohort study.Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities.INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units.The association between COPD and heart failure risk: a reviewPathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndromeCardiovascular injury and repair in chronic obstructive pulmonary disease.Experimental exposure to diesel exhaust increases arterial stiffness in man.Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care settingComputed tomography quantification of pulmonary vessels in chronic obstructive pulmonary disease as identified by 3D automated approach.Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.Update in chronic obstructive pulmonary disease 2008.Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitationRelationship between FEV1 and Cardiovascular Risk Factors in General Population without Airflow Limitation.A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links.Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.β-blockade: benefits beyond blood pressure reduction?Quantitative CT measurements of small pulmonary vessels in chronic obstructive pulmonary disease: do they change on follow-up scans?Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management.Human cerebral blood flow control during hypoxia: focus on chronic pulmonary obstructive disease (COPD) and obstructive sleep apnea (OSA).Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators.Pulmonary artery stiffness in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease.Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease.Relationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary disease.Arterial stiffness in symptomatic smokers with normal lung function.Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study.Increased risk of lung cancer among patients with bronchiectasis: a nationwide cohort study.Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery.Vascular dysfunction in chronic obstructive pulmonary disease.Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study.
P2860
Q23919501-0DF8C82C-E4C1-40C1-AB3B-B8FA76ECD115Q28602255-BC3D5F8A-C34E-4AE6-9FDE-FB64C0AFA703Q30494287-2C89864B-F305-4794-8CAA-1940341F55B8Q33878940-138A8A80-B936-4DCB-85B7-5F1F6C0A87FDQ34110404-3BECB036-534E-4DEE-8843-223FD8D77431Q34425006-752BB03F-C679-49E8-BFED-7767D0E7C61AQ35081435-52190E17-00F3-4958-94C6-8199575038EAQ35717467-F213B203-0522-4EF5-B883-FC600E83693BQ36068392-09206EBA-F49E-4B10-972B-D27940FB65C1Q36239420-FD01ECB7-FA03-48FE-89E9-C6DBD2476B51Q36443665-9AACA1E2-00CF-477A-B984-8C69466D08C0Q36797618-C5B2ED03-D301-4797-9C9E-49D4B9EEC260Q36980625-D923224A-D50E-4246-97E5-CF472A954419Q37015491-0751FC27-0C7A-4517-B7F3-4FDC2237E667Q37098445-4778B4EC-6816-4B16-8DB7-4E2616A46699Q37139092-1D32F262-8D5F-4E6B-AC72-EC5E409F3296Q37302927-03F1D2A1-B4DD-400E-BF5B-0806D12D0610Q37328950-61628431-3A8B-4972-B5F8-A6A9494A6F8DQ37393678-36D383DA-481B-453F-895A-417594738AF0Q37422824-1AF37364-D67F-496F-A1CC-01E970D96CEDQ37466082-BCA0EBFE-61AA-431E-9474-C5C6281E6661Q37492409-3009E06B-487A-4FE9-93AB-2E3C8820F24CQ37603596-DB511E74-2737-4CA2-BA2D-6A30E63EDEA6Q37644823-19EB5CFF-2A00-4D59-9C27-2FB664AF576CQ37940008-36FDEAA7-2806-4A09-9DE8-0C41F6D5DCD3Q37978685-0C7BA4A7-05BA-4B06-BA45-E7D9CE71B44DQ38267884-2F11D3F3-BA45-4180-AD21-DC1FD526496EQ38342003-C76DF5C0-3C7E-447C-ABFA-6555E1115D1DQ38629795-AAD189E4-E2C2-460F-AB1A-D61463625A61Q38751226-48697414-FD77-4BB9-BEE6-172FBB2409C5Q38794826-079633AB-66C3-4615-88B0-97AB8115638CQ38958179-8EAA3AA7-0F55-45FE-B60F-C92541001F44Q40158270-CCD1BF0F-4A67-46BE-BE5A-C739836836BAQ40840356-A3557689-834C-4D13-89B0-0830C947BA1AQ41076989-97BA5262-7F1A-47D6-AC42-AED360F6AE18Q41706534-DCDC677E-2579-4012-8923-BE9FF831C924Q43778593-AB32D18E-8BFA-44CD-A703-1588075382ACQ44231339-856E49F0-E2F8-4201-8AED-EE349A91D6E9Q45960606-8D0BE302-C42B-4E94-A7F8-43E06125A5A0Q47650579-C2E2A830-6A18-46A2-849D-3FD74D1A64B3
P2860
Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk
description
im November 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 16 November 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2008
@uk
name
Increased arterial stiffness i ...... increased cardiovascular risk
@en
Increased arterial stiffness i ...... increased cardiovascular risk
@nl
type
label
Increased arterial stiffness i ...... increased cardiovascular risk
@en
Increased arterial stiffness i ...... increased cardiovascular risk
@nl
prefLabel
Increased arterial stiffness i ...... increased cardiovascular risk
@en
Increased arterial stiffness i ...... increased cardiovascular risk
@nl
P2093
P50
P921
P356
P1433
P1476
Increased arterial stiffness i ...... increased cardiovascular risk
@en
P2093
C M McEniery
D Anderson
G A Frazer
I B Wilkinson
J J Miller
K Donaldson
S D Robinson
P304
P356
10.1136/THX.2007.083493
P407
P577
2007-11-16T00:00:00Z